7th Drug Formulation, Solubility and Bioavailability

Kongressthemen
When over 80% of APIs in development are poorly water-soluble, drug companies must rely increasingly on new formulation and delivery strategies to maximize bioavailability. ExL's 7th Drug Formulation, Solubility and Bioavailability conference helps you recognize the precise thresholds where an enabled formulation becomes necessary, as well as determine which method to use and how to predict and gauge its success.

Kongressorganizer (PCO)
Exl Events

Anmerkungen
Speakers: Rossitza Alargova Director, Formulations, INFINITY PHARMACEUTICALS, Gail Dempsey EOC and Director, Manufacturing Technologies, PIEDMONT ANIMAL HEALTH, Rakesh Dixit Vice President, RandD, Global Head, Biologics Safety, MEDIMMUNE

URLs: Brochure: https://go.evvnt.com/174423-1 Booking: https://go.evvnt.com/174423-2

Frau Alysha Parker